Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Felodipine alone or in combination for hypertension in Chinese patients
NCT02336607Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of felodipine in essential hypertension (4 arms), sponsored by AstraZeneca. Primary endpoint: Percentage of Subjects Reaching Blood Pressure Target (< 140/90 mmHg) at 14 weeks. Started Dec 2005; status: completed.
02
Drugs
felodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02336607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336607.